Merck & Co., Inc.
Could not find a ticker for this position, may be a filing error
A maker of prescription medicines and animal health products, Merck produces well-known drugs like the cancer treatment Keytruda and the HPV vaccine Gardasil, along with livestock and pet-care vaccines used by doctors, veterinarians, and farmers. Founded in 1891 as the American branch of a German family firm, the company was seized during World War I and later bought back, becoming an independent U.S. company that today goes by the name MSD outside North America. A fun quirk: its blockbuster Keytruda nearly got shelved — researchers originally set out to calm the immune system, not fight cancer.
Granted 467.5K · Sold 282.5K
Granted 90.6K · Sold 81.5K
Granted 71.3K
Granted 113.8K · Sold 40.0K
Granted 113.4K · Sold 40.0K
Granted 142.7K · Sold 80.3K
Granted 51.4K · Sold 50.7K
Granted 204.2K · Sold 171.1K
Granted 4.8K
Granted 552
Granted 50.0K · Sold 21.1K
Granted 12.3K · Sold 1.0K
Granted 54.0K · Sold 44.5K
Bought 15.0K
Granted 24.8K
Granted 14.8K · Sold 10.7K
Granted 8.3K
Bought 2.8K
Granted 9.4K · Sold 9.4K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Davis Robert MChairman, CEO & President, Director · 13 transactions | +65.7% | 450.4K | 467.5K | — | 282.5K |
| DeLuca Richard R.EVP&Pres, Merck Animal Heallth · 9 transactions | -15.8% | 325.7K | 90.6K | — | 81.5K |
| Chattopadhyay SanatExe V-P & Pres. MMD · 5 transactions | — | 258.3K | 71.3K | — | — |
| Guindo ChirfiEVP, Access, Policy & Comms · 11 transactions | +467.9% | 124.3K | 113.8K | — | 40.0K |
| Li Dean YExecutive VP & President, MRL · 10 transactions | +361.3% | 94.4K | 113.4K | — | 40.0K |
| Litchfield CarolineEVP & CFO · 9 transactions | +191.2% | 92.3K | 142.7K | — | 80.3K |
| Mizell StevenEVP, Chief HR Officer · 4 transactions | +224% | 74.3Kas of Feb 2024 | 51.4K | — | 50.7K |
| Zachary JenniferEVP, General Counsel · 13 transactions | +30.6% | 70.9K | 204.2K | — | 171.1K |
| Klobuchar Michael AEVP - Chief Strategy Officer · 3 transactions | +24.2% | 49.5Kas of May 2024 | 4.8K | — | — |
| Maraldo David R.EVP & Pres. MMD · 2 transactions | — | 44.9K | 552 | — | — |
| Williams David MichaelEVP,Chief Info&Digital Officer · 12 transactions | +186.8% | 31.7K | 50.0K | — | 21.1K |
| Romanelli JosephPresident, Human Health Int?l · 8 transactions | +41.7% | 28.7K | 12.3K | — | 1.0K |
| Oosthuizen Johannes JacobusEVP, Oncology & Int?l · 18 transactions | +13.4% | 21.9K | 54.0K | — | 44.5K |
| Baker Douglas M JrDirector · 1 transaction | +1500% | 16.0K | — | 15.0K | — |
| Larson Betty DEVP, Chief HR Officer · 6 transactions | — | 13.8K | 24.8K | — | — |
| Smart Dalton E. IIISVP Fin. - Global Controller · 20 transactions | — | 9.4K | 14.8K | — | 10.7K |
| Smart DaltonSVP Fin. - Global Controller · 10 transactions | — | 7.0Kas of Jan 2025 | 8.3K | — | — |
| Thulin Inge GDirector · 1 transaction | +2832.9% | 2.9K | — | 2.8K | — |
| Downing Cristal NChief Comm. & Public Afrs Ofcr · 3 transactions | — | 0 | 9.4K | — | 9.4K |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 3 years: -814.9K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.